Oral and systemic factors associated with increased levels of human immunodeficiency virus type 1 RNA in saliva

被引:31
作者
Shugars, DC [1 ]
Slade, GD
Patton, LL
Fiscus, SA
机构
[1] Univ N Carolina, Sch Dent, Dept Dent Ecol, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA
来源
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS | 2000年 / 89卷 / 04期
关键词
D O I
10.1016/S1079-2104(00)70124-7
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objective. The purpose of this investigation was to quantify human immunodeficiency virus type-1 (HIV-1) RNA in saliva and plasma and identify factors associated with increased salivary viral load. Study design. Forty HIV-1-seropositive adults underwent oral examinations to assess mucosal and periodontal health. Whole saliva was evaluated for HIV-1 RNA titer and occult blood. Plasma viral load, CD4 cell count, HIV-1 staging, and antiretroviral therapy data were obtained from medical records. Associations between salivary titers and oral/systemic parameters were analyzed by means of t tests, Wilcoxon signed rank tests, Pearson's correlation coefficient and analysis of covariance. Results, Forty-two percent of the subjects had detectable salivary HIV-1 RNA. Oral titers were highly correlated with plasma viral levels (r = 0.51, P < .01). HIV-associated periodontal disease (in particular, linear gingival erythema), severe gingival inflammation, and absence of antiretroviral therapy were associated with high salivary titers (P < .01). Conclusions. Substantial quantities of HIV-1 can be shed in the oral cavity, particularly when inflammatory conditions are present. Salivary titer may be a useful indicator of systemic viral burden.
引用
收藏
页码:432 / 440
页数:9
相关论文
共 45 条
[21]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND CYTOMEGALOVIRUS IN SALIVA [J].
LUCHT, E ;
ALBERT, J ;
LINDE, A ;
XU, WM ;
BRYTTING, M ;
LUNDEBERG, J ;
UHLEN, M ;
BRATT, G ;
SANDSTROM, E ;
HEIMDAHL, A ;
NORD, CE ;
WAHREN, B .
JOURNAL OF MEDICAL VIROLOGY, 1993, 39 (02) :156-162
[22]   SECRETORY LEUKOCYTE PROTEASE INHIBITOR - A HUMAN SALIVA PROTEIN EXHIBITING ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS-1 ACTIVITY IN-VITRO [J].
MCNEELY, TB ;
DEALY, M ;
DRIPPS, DJ ;
ORENSTEIN, JM ;
EISENBERG, SP ;
WAHL, SM .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01) :456-464
[23]   Prognosis in HIV-1 infection predicted by the quantity of virus in plasma [J].
Mellors, JW ;
Rinaldo, CR ;
Gupta, P ;
White, RM ;
Todd, JA ;
Kingsley, LA .
SCIENCE, 1996, 272 (5265) :1167-1170
[24]   RAPID AND SIMPLE PCR ASSAY FOR QUANTITATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA IN PLASMA - APPLICATION TO ACUTE RETROVIRAL INFECTION [J].
MULDER, J ;
MCKINNEY, N ;
CHRISTOPHERSON, C ;
SNINSKY, J ;
GREENFIELD, L ;
KWOK, S .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (02) :292-300
[25]  
Offenbacher S, 1996, Ann Periodontol, V1, P821, DOI 10.1902/annals.1996.1.1.821
[26]   TUMOR NECROSIS FACTOR-ALPHA AND INTERLEUKIN-1 STIMULATE THE HUMAN IMMUNODEFICIENCY VIRUS ENHANCER BY ACTIVATION OF THE NUCLEAR FACTOR KAPPA-B [J].
OSBORN, L ;
KUNKEL, S ;
NABEL, GJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (07) :2336-2340
[27]   Immunologic and viral markers of HIV-1 disease progression: Implications for dentistry [J].
Patton, LL ;
Shugars, DC .
JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 1999, 130 (09) :1313-1322
[28]   LOW-LEVEL OF CELL-FREE VIRUS DETECTED AT HIGH-FREQUENCY IN SALIVA FROM HIV-1-INFECTED INDIVIDUALS [J].
PHILLIPS, J ;
QURESHI, N ;
BARR, C ;
HENRARD, DR .
AIDS, 1994, 8 (07) :1011-1012
[29]  
Ramfjord SP., 1959, J PERIODONTOL, V30, P51, DOI DOI 10.1902/JOP.1959.30.1.51
[30]   HIV viral load markers in clinical practice [J].
Saag, MS ;
Holodniy, M ;
Kuritzkes, DR ;
OBrien, WA ;
Coombs, R ;
Poscher, ME ;
Jacobsen, DM ;
Shaw, GM ;
Richman, DD ;
Volberding, PA .
NATURE MEDICINE, 1996, 2 (06) :625-629